-
MissionWin a future for patients, create value for society
-
ValueCustomer-Centered, Employee-Valued
-
VisionDemonstrating excellent quality through data, dedicated to becoming an industry leader.
Guangzhou Royallee Cancer Center is a tertiary
oncology hospital solely invested by the RoyalleeGroup. lt is one of
three core projects initiated by International Wellness Research
Center of Sun Yat-senUniversity, and has been short-listed for
"Guangdong Modern Industry Top 500 projects"
The whole project was initiated in 2010 and funded with 1.5 billion RMB,
located at No.1 Ciji Road, Sino-Singapore Guangzhou Knowledge City,
Huangpu District, Guangzhou, Guangdong, China.
Royallee Cancer Center
willevolve into a high-end modern oncology hospital that integrates
examination, diagnosis, treatment oftumor and accurate prevention of
cancer as well as management of familial cancers and clinical
researchor clinical application. This prospect is based on the
JCl(An independent, not-for-profit organizationJoint Commission
International (JCl) accredits and certifies health care
organizations and programsacross the alobe, joint Commission
international accreditation and certification is recognized as
aglobal leader for health care quality of care and patient safety)
standard on design and construction ofhospitals already met and
curent medical industry plan implemented by SSGKC
Regular patient satisfaction surveys reveal that most patients highly commend our efficient and accurate diagnostic services, noting the demeanor of our staff, which eased their anxiety and boosted confidence in subsequent treatments.
Monthly patient satisfaction surveys show that patients highly rate our outpatient services, praising the smooth process, professionalism and patience of our staff, and expressing great satisfaction with the clinic environment.
Inpatient satisfaction surveys reveal patients are very pleased with our services, noting skilled and caring staff, as well as a comfortable environment that provides strong support for their recovery.